Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, SVY

Hahn Loeser & Parks Announces Launch of Biometric Privacy Practice Group in Chicago


CHICAGO, March 18, 2019 /PRNewswire/ -- Hahn Loeser & Parks LLP announced today it has established a new practice group?the Biometric Privacy Practice Group?to better support clients' needs in the areas of privacy and data protection. The new group will be chaired by partner Ian H. Fisher and will focus on claims relating to the Illinois Biometric Information Privacy Act (BIPA) and the emergence of biometric privacy issues across the country. Fisher and Gillian G. Lindsay will represent employers, timekeeping technology companies, and other clients using and implementing biometric data with BIPA and privacy compliance and class-action defense.

"The creation of this new practice group is a response to our growing experience in this emerging area of law," said Hahn Loeser's CEO & Managing Partner Marc J. Kessler. "Ian and his team are assisting clients in navigating cutting-edge issues in biometric privacy law and are well positioned to respond to the expanding legal needs in this area."

The launch of the Firm's Biometric Privacy Practice Group follows the January Illinois Supreme Court decision in Rosenbach v. Six Flags Entertainment Corp., et. al, which drastically reduced the threshold harm required for an individual to bring suit under BIPA.  Illinois has passed the strongest biometric privacy statute in the United States. BIPA provides aggrieved persons with a private right of action and significant statutory damages. Claims can be readily combined into class actions, exponentially increasing financial risk for businesses.

"The use of biometric data will expand and grow in ways we cannot predict," said Fisher. "We assist clients with implementing best practices for using biometric technology in their businesses; we reduce their potential risk."

Fisher noted that with the ruling in, Rosenbach in January, the Supreme Court made it much easier for workers to bring suit against their employers for technical violations of the state's biometric information privacy statute. Lindsay commented, "In the past two years, more than 200 class actions have been filed in Illinois, and that number will grow in response to this ruling. As companies integrate this type of emerging technology into their businesses, they need counsel who can help them navigate this new landscape."

Fisher and Lindsay just published an article -- "Biometric Technologies Create Big Liabilities" in the March 15, 2019 issue of FLASHPOINTS published by the Illinois Institute of Continuing Legal Education (IICLE). This article provides additional detail on the implications of BIPA and recommendations for companies to help mitigate their risk.

Hahn Loeser's Biometric Privacy Practice Group will provide three primary areas of service to its clients: BIPA Client Counseling & Compliance, BIPA Class Action Defense, and BIPA Insurance.

Hahn Loeser is one of just a few firms that have a practice group focused on this emerging area. Organizations that collect or maintain biometric information, such as fingerprints, iris scans, and face scans, in Illinois should ensure they are familiar with and follow BIPA's notice and consent requirements to limit their legal exposure. Learn more about Hahn Loeser's Biometric Privacy Practice Group here.

About Hahn Loeser
Hahn Loeser provides the full spectrum of legal services in one firm. With six offices and more than 115 attorneys, we represent large corporations, privately-held businesses, non-profit institutions, governmental entities and individuals across the country and around the world. Our attorneys have been recognized for their commitment to client service and their dedication to providing our clients with strategic solutions that help them attain their business objectives and achieve results.

Contact:
Erin Hawk, Director of Development & Marketing 
614.233.5109
[email protected] 

 

SOURCE Hahn Loeser & Parks LLP


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: